Physician

Mark A Cohen, MD

According to 2025 Medicare claims, Mark Cohen, MD (NPI: 1194785485) practices micrographic dermatologic surgery in the Kansas City, MO-KS market, with the plurality of this provider's patient population coming from Platte, MO. This provider's primary affiliated billing organization is KANSAS CITY SKIN AND CANCER CENTER, LLC (NPI: 1669670964; TIN: 260330277) and primary practice location at 64154-2558.

Cohen's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 744 traditional Medicare patients, billed 2,473 HCPCS/CPT codes, and received $711,784 in Medicare payments. The top billing code was 17311 (Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks). Part D data shows 349 prescription claims across 271 beneficiaries totaling $7,525 in drug costs, led by Cephalexin (Cephalexin). Open Payments data shows 106 records totaling $2,251. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $22,689 and ending at $7,525. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	705	3,762	$572,770
2016	1,063	6,015	$682,101
2017	1,073	6,315	$681,200
2018	1,059	5,238	$701,379
2019	805	3,544	$646,601
2020	729	2,818	$591,812
2021	633	2,120	$521,560
2022	693	2,390	$618,876
2023	710	2,369	$617,765
2024	744	2,473	$711,784

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	297	477	$22,689
2016	262	426	$23,304
2017	236	339	$16,090
2018	236	333	$49,984
2019	271	360	$30,946
2020	281	388	$7,749
2021	286	354	$4,440
2022	281	353	$5,739
2023	312	407	$4,764
2024	271	349	$7,525

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17311	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks	630	793	$476
17312	Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks	252	354	$326
12052	Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm	250	291	$124
12042	Intermediate repair of wound of neck, hands, feet, or genitals, 2.6-7.5 cm	68	70	$123
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	107	137	$63

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Cephalexin	Cephalexin	226	1,563	$1,109
Mupirocin	Mupirocin	42	745	$266
Doxycycline Hyclate	Doxycycline Hyclate	34	251	$245

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	106	$2,251	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark A. Cohen, MD?

Tedicare shows public-source Medicare data for Mark A. Cohen, MD (NPI 1194785485), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark A. Cohen, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mark A. Cohen, MD?

Mark A. Cohen, MD is linked to KANSAS CITY SKIN AND CANCER CENTER, LLC (billing NPI 1669670964) in the available physician profile data.

Does Mark A. Cohen, MD have Open Payments data?

Mark A. Cohen, MD has 106 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.